N/A
N=38
Effectiveness of Core Stabilization Exercise in Patients With Subacute Non-Specific Low Back Pain
Low Back Pain
Bottom Line
View on ClinicalTrials.gov: NCT02645760 ↗Enrolled (actual)
38
Serious AEs
0.0%
Results posted
Oct 2016
Primary outcome: Primary: Change From Baseline in Pain on 11- Point Numerical Rating Scale at Week 7 — 1.32; 3.63 units on a scale — p=<0.001
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Core stabilization exercise (Other); Conventional treatment (Other)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- Khon Kaen University
- Primary completion
- Jun 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change From Baseline in Pain on 11- Point Numerical Rating Scale at Week 7 |
1.32; 3.63 | <0.001 sig |
| SECONDARY Change From Baseline in Functional Disability on Roland-Morris Disability Questionnaire at Week 7 |
1.53; 4.89 | 0.009 sig |
| SECONDARY Change From Baseline in Back Range of Motion (Flexion) on Modified-modified Schober's Test at Week 7 |
5.32; 4.32 | 0.013 sig |
| SECONDARY Change From Baseline in Repositioning Error on Repositioning Test at Week 7 |
0.43; 0.67 | 0.012 sig |
Summary
The purpose of this study is to examines the effectiveness of Core stabilization exercise on pain intensity at rest, functional disability, lumbar movement and ability to perform repositioning tasks (joint position sense) in patients with subacute non-specific low back pain.
Eligibility Criteria
Inclusion Criteria
- Onset of back pain within 6 -12 weeks participants had no history of back pain for a period of 6 months prior to the current episode.
- Pain intensity measure by a numerical rating scale (0-10 NRS) and a score of pain at least 3 out of 10.
- Never receive the treatment by core stabilization exercise (CSE) during 3 months before participate in this study.
Exclusion Criteria
- Pregnancy
- Onset of serious spinal pathology: spinal fracture, spinal tumor or spinal infection.
- Cauda equina syndrome.
- Presented at least 2 out of 3 signs of neurological deficit
Data sourced from ClinicalTrials.gov (NCT02645760). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.